Efectos cardioprotectores de reducción de tamaño del infarto de miocardio…
717
11. Tao R.; Zhang J.; Vessey DA.; Honbo N.; Karliner JS. Deletion of the sphingosine kinase-1
gene influences cell fate during hypoxia and glucose deprivation in adult mouse
cardiomyocytes. Cardiovasc Res
74
(1), 56-63 (2007).
12. Jin ZQ.; Zhou HZ.; Zhu P.; Honbo N.; Mochly-Rosen D.; Messing RO.; Goetzl EJ.; Karliner JS.;
Gray MO. Cardioprotection mediated by sphingosine-1-phosphate and ganglioside GM-1 in
wild-type and PKC epsilon knockout mouse hearts. Am J Physiol Heart Circ Physiol
282
(6),
H1970-1977 (2002).
13. Lecour S.; Smith RM.; Woodward B.; Opie LH.; Rochette L.; Sack MN. Identification of a
novel role for sphingolipid signaling in TNF alpha and ischemic preconditioning mediated
cardioprotection. J Mol Cell Cardiol
34
(5), 509-518 (2002).
14. Duan HF.; Wang H.; Yi J.; Liu HJ.; Zhang QW.; Li LB.; Zhang T.; Lu Y.; Wu CT.; Wang LS.
Adenoviral gene transfer of sphingosine kinase 1 protects heart against
ischemia/reperfusion-induced injury and attenuates its postischemic failure. Hum Gene
Ther
18
(11), 1119-1128 (2007).
15. Means CK.; Xiao CY.; Li Z.; Zhang T.; Omens JH.; Ishii I.; Chun J.; Brown JH. Sphingosine 1-
phosphate S1P2 and S1P3 receptor-mediated Akt activation protects against in vivo
myocardial ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol
292
(6), H2944-
2951 (2007)
16. Brinkmann V.; Billich A.; Baumruker T.; Heining P.; Schmouder R.; Francis G.; Aradhye S.;
Burtin P. Fingolimod (FTY720), discovery and development of an oral drug to treat
multiple sclerosis. Nat Rev Drug Discov
9
(11), 883-897 (2010)
17. Kappos L.; Radue EW.; O'Connor P.; Polman C.; Hohlfeld R.; Calabresi P.; Selmaj K.;
Agoropoulou C.; Leyk M.; Zhang-Auberson L.; Burtin P. A placebo-controlled trial of oral
fingolimod in relapsing multiple sclerosis. N Engl J Med
362
(5), 387-401 (2010).
18. Cohen JA.; Barkhof F.; Comi G.; Hartung HP.; Khatri BO.; Montalban X.; Pelletier J.; Capra R.;
Gallo P.; Izquierdo G.; Tiel-Wilck K.; de Vera A.; Jin J.; Stites T.; Wu S.; Aradhye S.; Kappos L.
Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis. N Engl J Med
362
(5), 402-415 (2010)
19. Zhang J.; Honbo N.; Goetzl EJ.; Chatterjee K.; Karliner JS.; Gray MO. Signals from type 1
sphingosine 1-phosphate receptors enhance adult mouse cardiac myocyte survival during
hypoxia. Am J Physiol Heart Circ Physiol
293
(5), H3150-3158 (2007).
20. Hofmann U.; Burkard N.; Vogt C.; Thoma A.; Frantz S.; Ertl G.; Ritter O.; Bonz A. Protective
effects of sphingosine-1-phosphate receptor agonist treatment after myocardial
ischaemia-reperfusion. Cardiovasc Res
83
(2), 285-293 (2009).
21. Egom EE.; Mohamed TM.; Mamas MA.; Shi Y.; Liu W.; Chirico D.; Stringer SE.; Ke Y.;
Shaheen M.; Wang T.; Chacko S.; Wang X.; Solaro RJ.; Fath-Ordoubadi F.; Cartwright EJ.; Lei
M. Activation of Pak1/Akt/eNOS signaling following sphingosine-1-phosphate release as
part of a mechanism protecting cardiomyocytes against ischemic cell injury. Am J Physiol
Heart Circ Physiol
301
(4), H1487-1495 (2011).
22. Ibanez B.; Prat-Gonzalez S.; Speidl WS.; Vilahur G.; Pinero A.; Cimmino G.; Garcia MJ.;
Fuster V.; Sanz J.; Badimon JJ. Early metoprolol administration before coronary
reperfusion results in increased myocardial salvage, analysis of ischemic myocardium at
risk using cardiac magnetic resonance. Circulation
115
(23), 2909-2916 (2007).
23. Aletras AH.; Tilak GS.; Natanzon A.; Hsu LY.; Gonzalez FM.; Hoyt RF.; Jr..; Arai AE.
Retrospective determination of the area at risk for reperfused acute myocardial infarction
with T2-weighted cardiac magnetic resonance imaging, histopathological and
displacement encoding with stimulated echoes (DENSE) functional validations. Circulation
113
(15), 1865-1870 (2006).
24. Lang RM.; Bierig M.; Devereux RB.; Flachskampf FA.; Foster E.; Pellikka PA.; Picard MH.;
Roman MJ.; Seward J.; Shanewise JS.; Solomon SD.; Spencer KT.; Sutton MS.; Stewart WJ.
Recommendations for chamber quantification, a report from the American Society of
Echocardiography's Guidelines and Standards Committee and the Chamber Quantification
Writing Group.; developed in conjunction with the European Association of
Echocardiography.; a branch of the European Society of Cardiology. J Am Soc Echocardiogr
18
(12), 1440-1463 (2005)
25. Mor-Avi V.; Lang RM.; Badano LP.; Belohlavek M.; Cardim NM.; Derumeaux G.; Galderisi M.;
Marwick T.; Nagueh SF.; Sengupta PP.; Sicari R.; Smiseth OA.; Smulevitz B.; Takeuchi M.;
Thomas JD.; Vannan M.; Voigt JU.; Zamorano JL. Current and evolving echocardiographic
techniques for the quantitative evaluation of cardiac mechanics, ASE/EAE consensus
